US Patent 7229613 Method for lowering serum glucose

Patent 7229613 was granted and assigned to Genzyme on June, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 16 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 16 Sep, 2023

Edits made to:

Infobox (+2 properties)

Infobox

Patent Inventor Names

Joanne M. Donovan0

Steven K. Burke0

Edits on 1 Sep, 2023

"Add patent abstract"

Golden AI

edited on 1 Sep, 2023

Edits made to:

Article (+509 characters)

Article

Patent abstract

A method for treating hyperglycemia and/or reducing serum glucose levels in a patient that includes administering to the patient a therapeutically effective amount of an amine polymer is disclosed. In one embodiment, the amine polymer is aliphatic. Examples of polymers useful in an embodiment of the invention include sevelamer hydrogen chloride and colesevelam. The invention includes the use of amine polymers such as a cross-linked polymer characterized by a repeat unit having the formula:

Edits on 22 May, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 22 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌